FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2918571839> ?p ?o ?g. }

• W2918571839 endingPage "887" @default.
• W2918571839 startingPage "887" @default.
• W2918571839 abstract "DiNap [(E)-1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(naphthalen-1-yl)prop-2-en-1-one], an analog of a natural product (the chalcone flavokawain), was synthesized and characterized in this study. Porcine reproductive and respiratory syndrome virus (PRRSV) is the most challenging threat to the swine industry worldwide. Currently, commercially available vaccines are ineffective for controlling porcine reproductive and respiratory syndrome (PRRS) in pigs. Therefore, a pharmacological intervention may represent an alternative control measure for PRRSV infection. Hence, the present study evaluated the effects of DiNap on the replication of VR2332 (a prototype strain of type 2 PRRSV). Initially, in vitro antiviral assays against VR2332 were performed in MARC-145 cells and porcine alveolar macrophages (PAMs). Following this, a pilot study was conducted in a pig model to demonstrate the effects of DiNap following VR2332 infection. DiNap inhibited VR2332 replication in both cell lines in a dose-dependent manner, and viral growth was completely suppressed at concentrations ≥0.06 mM, without significant cytotoxicity. Consistent with these findings, in the pig study, DiNap also reduced viral loads in the serum and lungs and enhanced the weight gain of pigs following VR2332 infection, as indicated by comparison of the DiNap-treated groups to the untreated control (NC) group. In addition, DiNap-treated pigs had fewer gross and microscopic lesions in their lungs than NC pigs. Notably, virus transmission was also delayed by approximately 1 week in uninfected contact pigs within the same group after treatment with DiNap. Taken together, these results suggest that DiNap has potential anti-PRRSV activity and could be useful as a prophylactic or post-exposure treatment drug to control PRRSV infection in pigs." @default.
• W2918571839 created "2019-03-11" @default.
• W2918571839 creator A5008105713 @default.
• W2918571839 creator A5024156829 @default.
• W2918571839 creator A5034673378 @default.
• W2918571839 creator A5038223831 @default.
• W2918571839 creator A5040218956 @default.
• W2918571839 creator A5042687506 @default.
• W2918571839 creator A5045644420 @default.
• W2918571839 creator A5060166119 @default.
• W2918571839 creator A5069333143 @default.
• W2918571839 creator A5071266092 @default.
• W2918571839 creator A5079941395 @default.
• W2918571839 date "2019-03-03" @default.
• W2918571839 modified "2023-10-18" @default.
• W2918571839 title "Evaluation of the Inhibitory Effects of (E)-1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(naphthalen-1-yl)prop-2-en-1-one (DiNap), a Natural Product Analog, on the Replication of Type 2 PRRSV In Vitro and In Vivo" @default.
• W2918571839 cites W132455992 @default.
• W2918571839 cites W1967443404 @default.
• W2918571839 cites W1974957716 @default.
• W2918571839 cites W1979633272 @default.
• W2918571839 cites W1991698942 @default.
• W2918571839 cites W1991776895 @default.
• W2918571839 cites W1993249058 @default.
• W2918571839 cites W1997362033 @default.
• W2918571839 cites W1998128231 @default.
• W2918571839 cites W2002054210 @default.
• W2918571839 cites W2002116617 @default.
• W2918571839 cites W2016676329 @default.
• W2918571839 cites W2017164093 @default.
• W2918571839 cites W2020816047 @default.
• W2918571839 cites W2022506220 @default.
• W2918571839 cites W2022908914 @default.
• W2918571839 cites W2024282538 @default.
• W2918571839 cites W2025017827 @default.
• W2918571839 cites W2032636223 @default.
• W2918571839 cites W2041381307 @default.
• W2918571839 cites W2046318806 @default.
• W2918571839 cites W2060270933 @default.
• W2918571839 cites W2066475950 @default.
• W2918571839 cites W2066926911 @default.
• W2918571839 cites W2070822454 @default.
• W2918571839 cites W2071329684 @default.
• W2918571839 cites W2074199059 @default.
• W2918571839 cites W2078152019 @default.
• W2918571839 cites W2083443250 @default.
• W2918571839 cites W2085888394 @default.
• W2918571839 cites W2093853846 @default.
• W2918571839 cites W2094768851 @default.
• W2918571839 cites W2100618023 @default.
• W2918571839 cites W2114918609 @default.
• W2918571839 cites W2119380875 @default.
• W2918571839 cites W2127899004 @default.
• W2918571839 cites W2133751581 @default.
• W2918571839 cites W2140296277 @default.
• W2918571839 cites W2147640974 @default.
• W2918571839 cites W2162659591 @default.
• W2918571839 cites W2164735889 @default.
• W2918571839 cites W2165535479 @default.
• W2918571839 cites W2170733889 @default.
• W2918571839 cites W2284489385 @default.
• W2918571839 cites W2319864196 @default.
• W2918571839 cites W2386403312 @default.
• W2918571839 cites W2412139674 @default.
• W2918571839 cites W2558099105 @default.
• W2918571839 cites W2604350577 @default.
• W2918571839 cites W2623648302 @default.
• W2918571839 cites W2760412909 @default.
• W2918571839 cites W2951864513 @default.
• W2918571839 cites W4233606336 @default.
• W2918571839 cites W4237730567 @default.
• W2918571839 cites W575415440 @default.
• W2918571839 cites W857845772 @default.
• W2918571839 doi "https://doi.org/10.3390/molecules24050887" @default.
• W2918571839 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6429065" @default.
• W2918571839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30832429" @default.
• W2918571839 hasPublicationYear "2019" @default.
• W2918571839 type Work @default.
• W2918571839 sameAs 2918571839 @default.
• W2918571839 citedByCount "1" @default.
• W2918571839 countsByYear W29185718392023 @default.
• W2918571839 crossrefType "journal-article" @default.
• W2918571839 hasAuthorship W2918571839A5008105713 @default.
• W2918571839 hasAuthorship W2918571839A5024156829 @default.
• W2918571839 hasAuthorship W2918571839A5034673378 @default.
• W2918571839 hasAuthorship W2918571839A5038223831 @default.
• W2918571839 hasAuthorship W2918571839A5040218956 @default.
• W2918571839 hasAuthorship W2918571839A5042687506 @default.
• W2918571839 hasAuthorship W2918571839A5045644420 @default.
• W2918571839 hasAuthorship W2918571839A5060166119 @default.
• W2918571839 hasAuthorship W2918571839A5069333143 @default.
• W2918571839 hasAuthorship W2918571839A5071266092 @default.
• W2918571839 hasAuthorship W2918571839A5079941395 @default.
• W2918571839 hasBestOaLocation W29185718391 @default.
• W2918571839 hasConcept C109316439 @default.
• W2918571839 hasConcept C126322002 @default.
• W2918571839 hasConcept C140704245 @default.
• W2918571839 hasConcept C159047783 @default.
• W2918571839 hasConcept C202751555 @default.

• next